Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for RNA

Stock Name	Avidity Biosciences Inc
Ticker	RNA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05370A1088

Show aggregate RNA holdings

News associated with RNA

Avidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at Roth Capital: Roth Capital started coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report released on Wednesday, Marketbeat.com reports. The brokerage issued a buy rating and a $62.00 price objective on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. Wolfe Research began coverage on […] - 2025-09-18 04:26:54
Bank of America Raises Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its target price raised by research analysts at Bank of America from $56.00 to $65.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective suggests a potential upside of 56.85% from […] - 2025-09-17 02:38:42
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 14:49:56
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 12:32:21
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:58:14
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:14:12
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 08:20:54
Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $67.00: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are presently covering the firm, Marketbeat.com reports. Seventeen equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […] - 2025-09-12 02:32:51
Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-11 20:38:25
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 20:20:22
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 19:48:54
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes: The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:03
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:02
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:55:25
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations: The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:50:08
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 4.2% After Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price dropped 4.2% on Monday after an insider sold shares in the company. The stock traded as low as $44.55 and last traded at $44.51. Approximately 1,095,468 shares changed hands during trading, a decline of 40% from the average daily volume of 1,834,316 shares. The stock […] - 2025-08-20 02:34:50
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down on Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down prior to trading on Monday after an insider sold shares in the company. The stock had previously closed at $46.29, but opened at $44.46. Avidity Biosciences shares last traded at $44.45, with a volume of 505,071 shares. Specifically, insider Steven George Hughes sold […] - 2025-08-12 02:18:50
Barclays Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $62.00: Avidity Biosciences (NASDAQ:RNA – Free Report) had its price target boosted by Barclays from $59.00 to $62.00 in a research note released on Friday,Benzinga reports. Barclays currently has an overweight rating on the biotechnology company’s stock. A number of other brokerages also recently commented on RNA. Bank of America lifted their price objective on Avidity […] - 2025-08-11 03:50:56
Oppenheimer Asset Management Inc. Invests $226,000 in Avidity Biosciences, Inc. (NASDAQ:RNA): Oppenheimer Asset Management Inc. bought a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 7,657 shares of the biotechnology company’s stock, valued at approximately $226,000. Several other hedge funds have also modified their holdings of the stock. Parallel Advisors LLC raised […] - 2025-07-01 04:52:51
The Implied Analyst 12-Month Target For ESML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 13:02:45
Avidity Biosciences (NASDAQ:RNA) Now Covered by Sanford C. Bernstein: Investment analysts at Sanford C. Bernstein began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage set an “outperform” rating and a $50.00 price target on the biotechnology company’s stock. Sanford C. Bernstein’s price target indicates a potential upside of […] - 2025-06-26 02:48:48
Avidity Biosciences (NASDAQ:RNA) Earns Outperform Rating from Analysts at Wolfe Research: Equities research analysts at Wolfe Research assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $55.00 price target on the biotechnology company’s stock. Wolfe Research’s price objective points to a potential upside of 87.59% from […] - 2025-06-19 02:42:48
Assenagon Asset Management S.A. Raises Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA): Assenagon Asset Management S.A. raised its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 411.3% during the 1st quarter, Holdings Channel reports. The fund owned 207,372 shares of the biotechnology company’s stock after purchasing an additional 166,813 shares during the period. Assenagon Asset Management S.A.’s holdings in Avidity Biosciences were worth […] - 2025-06-15 05:44:49
Chardan Capital Forecasts Strong Price Appreciation for Avidity Biosciences (NASDAQ:RNA) Stock: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective raised by research analysts at Chardan Capital from $65.00 to $75.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Chardan Capital’s price target would indicate a potential upside of 123.08% from the company’s […] - 2025-06-11 04:58:52
Avidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Bank of America Analyst Says: Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective hoisted by stock analysts at Bank of America from $48.00 to $54.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target would indicate a potential upside of 60.62% from […] - 2025-06-11 03:00:54
Avidity Biosciences (NASDAQ:RNA) Shares Gap Up Following Analyst Upgrade: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) shares gapped up before the market opened on Monday after Citigroup raised their price target on the stock from $70.00 to $75.00. The stock had previously closed at $36.24, but opened at $38.00. Citigroup currently has a buy rating on the stock. Avidity Biosciences shares last traded […] - 2025-06-11 02:08:44
Traders Purchase Large Volume of Avidity Biosciences Put Options (NASDAQ:RNA): Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders acquired 7,058 put options on the company. This is an increase of 1,411% compared to the typical daily volume of 467 put options. Avidity Biosciences Price Performance Shares of Avidity Biosciences stock opened at […] - 2025-06-06 05:14:54
Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $66.38: Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued a report on the stock in […] - 2025-06-04 02:36:49

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc RNA holdings

Date	Number of RNA Shares Held	Base Market Value of RNA Shares	Local Market Value of RNA Shares	Change in RNA Shares Held	Change in RNA Base Value	Current Price per RNA Share Held	Previous Price per RNA Share Held
2025-12-24 (Wednesday)	41,724	USD 3,011,638	USD 3,011,638	0	USD 1,669	USD 72.18	USD 72.14
2025-12-23 (Tuesday)	41,724	USD 3,009,969	USD 3,009,969	-147	USD -13,117	USD 72.14	USD 72.2
2025-12-22 (Monday)	41,871	USD 3,023,086	USD 3,023,086	0	USD -5,862	USD 72.2	USD 72.34
2025-12-19 (Friday)	41,871	USD 3,028,948	USD 3,028,948	0	USD 8,583	USD 72.34	USD 72.135
2025-12-18 (Thursday)	41,871	USD 3,020,365	USD 3,020,365	0	USD 11,096	USD 72.135	USD 71.87
2025-12-17 (Wednesday)	41,871	USD 3,009,269	USD 3,009,269	0	USD -4,187	USD 71.87	USD 71.97
2025-12-16 (Tuesday)	41,871	USD 3,013,456	USD 3,013,456	0	USD 4,606	USD 71.97	USD 71.86
2025-12-15 (Monday)	41,871	USD 3,008,850	USD 3,008,850	0	USD 1,256	USD 71.86	USD 71.83
2025-12-12 (Friday)	41,871	USD 3,007,594	USD 3,007,594	0	USD 9,630	USD 71.83	USD 71.6
2025-12-11 (Thursday)	41,871	USD 2,997,964	USD 2,997,964	0	USD 10,468	USD 71.6	USD 71.35
2025-12-10 (Wednesday)	41,871	USD 2,987,496	USD 2,987,496	0	USD 2,094	USD 71.35	USD 71.3
2025-12-09 (Tuesday)	41,871	USD 2,985,402	USD 2,985,402	0	USD 1,675	USD 71.3	USD 71.26

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RNA by Blackrock for IE00B3VWM098

Show aggregate share trades of RNA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-23 SELL -147 72.190 72.050 72.064 USD -10,593 41.13 Loss of -4,547 on sale
2025-12-03 SELL -735 71.752 71.560 71.579 USD -52,611 39.10 Loss of -23,874 on sale
2025-12-02 BUY 294 71.660 71.120 71.174 USD 20,925 38.94
2025-11-25 SELL -441 71.620 71.060 71.116 USD -31,362 38.15 Loss of -14,539 on sale
2025-11-24 BUY 16,402 71.300 70.695 70.756 USD 1,160,532 37.99
2025-11-17 SELL -979 71.045 70.510 70.564 USD -69,082 37.16 Loss of -32,699 on sale
2025-11-12 SELL -89 70.980 70.550 70.593 USD -6,283 36.65 Loss of -3,021 on sale
2025-11-06 SELL -89 69.860 69.770 69.779 USD -6,210 35.95 Loss of -3,011 on sale
2025-11-05 SELL -890 69.850 69.795 69.800 USD -62,122 35.77 Loss of -30,283 on sale
2025-11-04 SELL -178 69.870 69.760 69.771 USD -12,419 35.60 Loss of -6,083 on sale
2025-11-03 SELL -178 69.880 69.760 69.772 USD -12,419 35.41 Loss of -6,116 on sale
2025-10-28 BUY 267 69.930 70.000 69.993 USD 18,688 34.67
2025-10-24 SELL -89 49.150 50.250 50.140 USD -4,462 34.40 Loss of -1,401 on sale
2025-10-15 BUY 534 50.470 51.490 51.388 USD 27,441 33.83
2025-10-02 BUY 89 44.180 44.190 44.189 USD 3,933 33.70
2025-09-30 BUY 178 43.570 43.690 43.678 USD 7,775 33.59
2025-08-21 SELL -105 44.660 44.940 44.912 USD -4,716 33.33 Loss of -1,216 on sale
2025-07-31 BUY 315 36.710 38.220 38.069 USD 11,992 33.24
2025-06-30 SELL -210 28.400 29.733 29.600 USD -6,216 33.42 Profit of 801 on sale
2025-06-25 SELL -105 29.900 30.020 30.008 USD -3,151 33.50 Profit of 366 on sale
2025-06-20 SELL -210 29.310 29.650 29.616 USD -6,219 33.58 Profit of 833 on sale
2025-05-30 SELL -8,665 30.980 31.790 31.709 USD -274,758 33.74 Profit of 17,587 on sale
2025-05-23 BUY 135 30.580 30.770 30.751 USD 4,151 33.86
2025-05-19 SELL -135 30.220 31.180 31.084 USD -4,196 33.96 Profit of 389 on sale
2025-05-15 SELL -405 28.970 29.090 29.078 USD -11,777 34.04 Profit of 2,010 on sale
2025-05-12 SELL -135 29.330 31.195 31.008 USD -4,186 34.17 Profit of 427 on sale
2025-05-09 SELL -135 27.870 30.250 30.012 USD -4,052 34.23 Profit of 569 on sale
2025-04-30 SELL -135 32.650 32.970 32.938 USD -4,447 34.51 Profit of 212 on sale
2025-04-24 SELL -270 30.930 31.030 31.020 USD -8,375 34.64 Profit of 977 on sale
2025-04-17 SELL -135 26.660 27.020 26.984 USD -3,643 34.97 Profit of 1,078 on sale
2025-04-15 SELL -405 26.680 27.670 27.571 USD -11,166 35.16 Profit of 3,073 on sale
2025-04-14 SELL -405 26.910 27.130 27.108 USD -10,979 35.25 Profit of 3,297 on sale
2025-04-09 SELL -540 24.800 25.560 25.484 USD -13,761 35.61 Profit of 5,465 on sale
2025-04-07 SELL -945 25.480 27.450 27.253 USD -25,754 35.86 Profit of 8,131 on sale
2025-04-04 SELL -1,350 26.570 27.825 27.700 USD -37,394 35.97 Profit of 11,160 on sale
2025-03-31 BUY 135 29.520 30.245 30.173 USD 4,073 36.23
2025-03-19 SELL -270 31.720 31.880 31.864 USD -8,603 36.70 Profit of 1,307 on sale
2025-03-14 SELL -810 31.110 33.160 32.955 USD -26,694 36.91 Profit of 3,204 on sale
2025-03-13 SELL -270 32.130 36.380 35.955 USD -9,708 36.98 Profit of 277 on sale
2025-03-12 SELL -4,590 32.610 32.690 32.682 USD -150,010 37.04 Profit of 20,015 on sale
2025-03-07 SELL -270 30.290 30.970 30.902 USD -8,344 37.36 Profit of 1,745 on sale
2025-03-06 SELL -405 30.350 31.000 30.935 USD -12,529 37.47 Profit of 2,647 on sale
2025-03-03 SELL -135 29.220 30.270 30.165 USD -4,072 37.88 Profit of 1,041 on sale
2025-02-28 SELL -810 30.640 30.770 30.757 USD -24,913 38.00 Profit of 5,863 on sale
2025-02-26 SELL -135 29.650 30.280 30.217 USD -4,079 38.29 Profit of 1,090 on sale
2025-02-25 SELL -405 29.160 31.180 30.978 USD -12,546 38.45 Profit of 3,024 on sale
2025-02-18 BUY 675 32.000 33.155 33.039 USD 22,302 39.09
2025-02-13 BUY 135 33.020 33.190 33.173 USD 4,478 39.48
2025-02-12 BUY 135 31.830 33.000 32.883 USD 4,439 39.64
2025-02-11 BUY 405 33.790 34.140 34.105 USD 13,813 39.76
2025-02-06 BUY 1,215 35.110 35.250 35.236 USD 42,812 40.09
2025-01-27 BUY 135 30.440 31.770 31.637 USD 4,271 41.73
2024-12-30 BUY 675 29.180 29.990 29.909 USD 20,189 43.15
2024-12-06 BUY 540 38.270 38.858 38.799 USD 20,952 43.76
2024-12-05 BUY 135 36.880 38.100 37.978 USD 5,127 44.00
2024-12-04 BUY 675 37.930 39.605 39.437 USD 26,620 44.21
2024-11-29 BUY 675 43.030 43.580 43.525 USD 29,379 44.61
2024-11-27 BUY 540 43.330 44.515 44.396 USD 23,974 44.72
2024-11-26 BUY 135 43.800 45.980 45.762 USD 6,178 44.76
2024-11-25 BUY 2,816 45.130 45.980 45.895 USD 129,240 44.74
2024-11-21 BUY 635 42.560 44.680 44.468 USD 28,237 44.93
2024-11-20 BUY 381 43.650 44.640 44.541 USD 16,970 45.01
2024-11-18 BUY 1,514 41.350 42.320 42.223 USD 63,926 45.34
2024-11-12 BUY 1,008 46.730 47.990 47.864 USD 48,247 45.25
2024-11-08 BUY 630 46.720 47.295 47.237 USD 29,760 45.15
2024-11-07 BUY 1,890 47.510 48.725 48.603 USD 91,861 44.96
2024-11-06 BUY 252 47.240 47.300 47.294 USD 11,918 44.78
2024-10-31 BUY 126 42.260 43.170 43.079 USD 5,428 45.41
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-23	SELL	-147	72.190	72.050	72.064	USD -10,593	41.13 Loss of -4,547 on sale
2025-12-03	SELL	-735	71.752	71.560	71.579	USD -52,611	39.10 Loss of -23,874 on sale
2025-12-02	BUY	294	71.660	71.120	71.174	USD 20,925	38.94
2025-11-25	SELL	-441	71.620	71.060	71.116	USD -31,362	38.15 Loss of -14,539 on sale
2025-11-24	BUY	16,402	71.300	70.695	70.756	USD 1,160,532	37.99
2025-11-17	SELL	-979	71.045	70.510	70.564	USD -69,082	37.16 Loss of -32,699 on sale
2025-11-12	SELL	-89	70.980	70.550	70.593	USD -6,283	36.65 Loss of -3,021 on sale
2025-11-06	SELL	-89	69.860	69.770	69.779	USD -6,210	35.95 Loss of -3,011 on sale
2025-11-05	SELL	-890	69.850	69.795	69.800	USD -62,122	35.77 Loss of -30,283 on sale
2025-11-04	SELL	-178	69.870	69.760	69.771	USD -12,419	35.60 Loss of -6,083 on sale
2025-11-03	SELL	-178	69.880	69.760	69.772	USD -12,419	35.41 Loss of -6,116 on sale
2025-10-28	BUY	267	69.930	70.000	69.993	USD 18,688	34.67
2025-10-24	SELL	-89	49.150	50.250	50.140	USD -4,462	34.40 Loss of -1,401 on sale
2025-10-15	BUY	534	50.470	51.490	51.388	USD 27,441	33.83
2025-10-02	BUY	89	44.180	44.190	44.189	USD 3,933	33.70
2025-09-30	BUY	178	43.570	43.690	43.678	USD 7,775	33.59
2025-08-21	SELL	-105	44.660	44.940	44.912	USD -4,716	33.33 Loss of -1,216 on sale
2025-07-31	BUY	315	36.710	38.220	38.069	USD 11,992	33.24
2025-06-30	SELL	-210	28.400	29.733	29.600	USD -6,216	33.42 Profit of 801 on sale
2025-06-25	SELL	-105	29.900	30.020	30.008	USD -3,151	33.50 Profit of 366 on sale
2025-06-20	SELL	-210	29.310	29.650	29.616	USD -6,219	33.58 Profit of 833 on sale
2025-05-30	SELL	-8,665	30.980	31.790	31.709	USD -274,758	33.74 Profit of 17,587 on sale
2025-05-23	BUY	135	30.580	30.770	30.751	USD 4,151	33.86
2025-05-19	SELL	-135	30.220	31.180	31.084	USD -4,196	33.96 Profit of 389 on sale
2025-05-15	SELL	-405	28.970	29.090	29.078	USD -11,777	34.04 Profit of 2,010 on sale
2025-05-12	SELL	-135	29.330	31.195	31.008	USD -4,186	34.17 Profit of 427 on sale
2025-05-09	SELL	-135	27.870	30.250	30.012	USD -4,052	34.23 Profit of 569 on sale
2025-04-30	SELL	-135	32.650	32.970	32.938	USD -4,447	34.51 Profit of 212 on sale
2025-04-24	SELL	-270	30.930	31.030	31.020	USD -8,375	34.64 Profit of 977 on sale
2025-04-17	SELL	-135	26.660	27.020	26.984	USD -3,643	34.97 Profit of 1,078 on sale
2025-04-15	SELL	-405	26.680	27.670	27.571	USD -11,166	35.16 Profit of 3,073 on sale
2025-04-14	SELL	-405	26.910	27.130	27.108	USD -10,979	35.25 Profit of 3,297 on sale
2025-04-09	SELL	-540	24.800	25.560	25.484	USD -13,761	35.61 Profit of 5,465 on sale
2025-04-07	SELL	-945	25.480	27.450	27.253	USD -25,754	35.86 Profit of 8,131 on sale
2025-04-04	SELL	-1,350	26.570	27.825	27.700	USD -37,394	35.97 Profit of 11,160 on sale
2025-03-31	BUY	135	29.520	30.245	30.173	USD 4,073	36.23
2025-03-19	SELL	-270	31.720	31.880	31.864	USD -8,603	36.70 Profit of 1,307 on sale
2025-03-14	SELL	-810	31.110	33.160	32.955	USD -26,694	36.91 Profit of 3,204 on sale
2025-03-13	SELL	-270	32.130	36.380	35.955	USD -9,708	36.98 Profit of 277 on sale
2025-03-12	SELL	-4,590	32.610	32.690	32.682	USD -150,010	37.04 Profit of 20,015 on sale
2025-03-07	SELL	-270	30.290	30.970	30.902	USD -8,344	37.36 Profit of 1,745 on sale
2025-03-06	SELL	-405	30.350	31.000	30.935	USD -12,529	37.47 Profit of 2,647 on sale
2025-03-03	SELL	-135	29.220	30.270	30.165	USD -4,072	37.88 Profit of 1,041 on sale
2025-02-28	SELL	-810	30.640	30.770	30.757	USD -24,913	38.00 Profit of 5,863 on sale
2025-02-26	SELL	-135	29.650	30.280	30.217	USD -4,079	38.29 Profit of 1,090 on sale
2025-02-25	SELL	-405	29.160	31.180	30.978	USD -12,546	38.45 Profit of 3,024 on sale
2025-02-18	BUY	675	32.000	33.155	33.039	USD 22,302	39.09
2025-02-13	BUY	135	33.020	33.190	33.173	USD 4,478	39.48
2025-02-12	BUY	135	31.830	33.000	32.883	USD 4,439	39.64
2025-02-11	BUY	405	33.790	34.140	34.105	USD 13,813	39.76
2025-02-06	BUY	1,215	35.110	35.250	35.236	USD 42,812	40.09
2025-01-27	BUY	135	30.440	31.770	31.637	USD 4,271	41.73
2024-12-30	BUY	675	29.180	29.990	29.909	USD 20,189	43.15
2024-12-06	BUY	540	38.270	38.858	38.799	USD 20,952	43.76
2024-12-05	BUY	135	36.880	38.100	37.978	USD 5,127	44.00
2024-12-04	BUY	675	37.930	39.605	39.437	USD 26,620	44.21
2024-11-29	BUY	675	43.030	43.580	43.525	USD 29,379	44.61
2024-11-27	BUY	540	43.330	44.515	44.396	USD 23,974	44.72
2024-11-26	BUY	135	43.800	45.980	45.762	USD 6,178	44.76
2024-11-25	BUY	2,816	45.130	45.980	45.895	USD 129,240	44.74
2024-11-21	BUY	635	42.560	44.680	44.468	USD 28,237	44.93
2024-11-20	BUY	381	43.650	44.640	44.541	USD 16,970	45.01
2024-11-18	BUY	1,514	41.350	42.320	42.223	USD 63,926	45.34
2024-11-12	BUY	1,008	46.730	47.990	47.864	USD 48,247	45.25
2024-11-08	BUY	630	46.720	47.295	47.237	USD 29,760	45.15
2024-11-07	BUY	1,890	47.510	48.725	48.603	USD 91,861	44.96
2024-11-06	BUY	252	47.240	47.300	47.294	USD 11,918	44.78
2024-10-31	BUY	126	42.260	43.170	43.079	USD 5,428	45.41

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RNA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	479,193	730	670,240	71.5%
2025-09-18	554,478	0	762,941	72.7%
2025-09-17	562,186	8,483	864,658	65.0%
2025-09-16	474,349	8,279	736,380	64.4%
2025-09-15	1,254,254	53,512	2,429,041	51.6%
2025-09-12	1,851,579	59,324	3,704,572	50.0%
2025-09-11	2,661,160	79,723	4,334,246	61.4%
2025-09-10	533,839	2,174	1,145,716	46.6%
2025-09-09	711,392	589	1,263,078	56.3%
2025-09-08	512,030	2,000	961,959	53.2%
2025-09-05	728,043	8,553	1,497,260	48.6%
2025-09-04	254,612	4,625	487,032	52.3%
2025-09-03	439,832	2,800	971,692	45.3%
2025-09-02	548,455	942	1,130,707	48.5%
2025-08-29	347,269	2,984	585,144	59.3%
2025-08-28	578,734	4,472	1,073,432	53.9%
2025-08-27	336,047	0	550,225	61.1%
2025-08-26	378,994	2,387	558,606	67.8%
2025-08-25	291,957	1,364	443,822	65.8%
2025-08-22	421,554	692	673,648	62.6%
2025-08-21	266,829	176	391,203	68.2%
2025-08-20	380,047	5,788	513,494	74.0%
2025-08-19	407,186	3,755	777,005	52.4%
2025-08-18	409,017	559	711,246	57.5%
2025-08-15	644,114	11,248	1,061,732	60.7%
2025-08-14	518,133	4,263	934,468	55.4%
2025-08-13	470,039	6,345	1,247,535	37.7%
2025-08-12	644,525	1,910	1,247,028	51.7%
2025-08-11	630,303	1,012	1,400,171	45.0%
2025-08-08	1,234,510	7,440	1,550,082	79.6%
2025-08-07	968,859	9,462	1,759,643	55.1%
2025-08-06	4,793,692	51,980	7,935,195	60.4%
2025-08-05	629,962	300	815,840	77.2%
2025-08-04	714,343	2,536	909,307	78.6%
2025-08-01	617,309	125	914,039	67.5%
2025-07-31	719,980	1,251	991,994	72.6%
2025-07-30	982,398	4,488	1,328,739	73.9%
2025-07-29	840,665	611	1,127,354	74.6%
2025-07-28	950,575	200	1,206,410	78.8%
2025-07-25	1,580,852	2,029	2,976,369	53.1%
2025-07-24	208,086	524	359,808	57.8%
2025-07-23	370,509	930	653,642	56.7%
2025-07-22	302,007	212	452,625	66.7%
2025-07-21	489,543	101	967,132	50.6%
2025-07-18	779,140	101	1,270,545	61.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE